Korro Bio’s (KRRO) Outperform Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Korro Bio (NASDAQ:KRRO – Free Report) in a report published on Thursday, Benzinga reports. Royal Bank of Canada currently has a $95.00 target price on the stock. A number of other research firms also recently weighed in on KRRO. HC Wainwright reissued a buy […]

Leave a Reply

Your email address will not be published.

Previous post Heidrick & Struggles International’s (HSII) “Outperform” Rating Reaffirmed at Barrington Research
Next post Morgan Stanley Boosts MercadoLibre (NASDAQ:MELI) Price Target to $2,500.00